Strategic Wealth Investment Group LLC bought a new position in McKesson Co. (NYSE:MCK – Free Report) during the 4th quarter, HoldingsChannel reports. The firm bought 364 shares of the company’s stock, valued at approximately $207,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in MCK. Synergy Asset Management LLC acquired a new stake in McKesson during the 4th quarter worth approximately $32,000. MidAtlantic Capital Management Inc. bought a new stake in shares of McKesson during the third quarter worth $29,000. Crews Bank & Trust acquired a new stake in shares of McKesson during the fourth quarter worth $33,000. Wolff Wiese Magana LLC lifted its position in McKesson by 742.9% in the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after acquiring an additional 52 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new position in McKesson in the 3rd quarter worth $31,000. 85.07% of the stock is owned by institutional investors.
Insider Activity
In related news, EVP Leann B. Smith sold 579 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the transaction, the executive vice president now owns 864 shares in the company, valued at approximately $494,890.56. This represents a 40.12 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.11% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on McKesson
McKesson Stock Performance
Shares of NYSE:MCK opened at $594.85 on Friday. McKesson Co. has a 52-week low of $464.42 and a 52-week high of $637.51. The company has a market capitalization of $75.51 billion, a P/E ratio of 30.81, a price-to-earnings-growth ratio of 1.30 and a beta of 0.52. The company has a 50-day simple moving average of $591.35 and a 200 day simple moving average of $562.12.
McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. The company had revenue of $93.65 billion during the quarter, compared to analysts’ expectations of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business’s revenue was up 21.3% on a year-over-year basis. During the same period last year, the firm posted $6.23 earnings per share. As a group, equities analysts forecast that McKesson Co. will post 32.72 earnings per share for the current year.
McKesson Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be issued a $0.71 dividend. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.48%. McKesson’s dividend payout ratio is currently 14.71%.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Nebius Group: Market Overreaction or Real AI Disruption?
- What to Know About Investing in Penny Stocks
- The Best Way to Invest in Gold Is…
- How to Invest in Insurance Companies: A Guide
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.